“We are positioned to move forward with either the Bausch + Lomb or Solta IPO quickly when market conditions are right for each of them,” CEO Joseph Papa says at J.P. Morgan conference, but the firm’s “next step” in the process of separating the two businesses was filing with the SEC an IPO registration for Bausch + Lomb.

Republican opposition to Califf over agency’s recent move to relax its Mifeprex restrictions is ominous since, in order be confirmed as commissioner, he’ll need enough GOP votes to make up for Democratic opposition over his opioid track record and connections to pharma industry.

A round-up of the latest health and wellness appointments: GSK makes addition to senior management teams in Europe; Reckitt appoints general counsel; and Norgine announces CEO change.

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

BBB National Programs’ appeals panel agrees with National Advertising Division that PLx should modify TV ad to clearly and conspicuously disclose that “clinically shown to cause fewer ulcers than plain aspirin” refers to Vazalore 325 mg and not 81-mg dose.

France's self-medication market lags behind its European rivals. Why is that? A skeptical and over-cautious government and a stifling regulatory system may provide at least part of the answer, the Global Self-Care Federation's recently published Self-Care Readiness Index suggests.  

Republican opposition to Califf over agency’s recent move to relax its Mifeprex restrictions is ominous since, in order be confirmed as commissioner, he’ll need enough GOP votes to make up for Democratic opposition over his opioid track record and connections to pharma industry.

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

NARB panel concluded #1 claims challenged by Oral-B floss products marketer P&G aren’t supported by acceptable evidence that the type of product the claim referenced – flossers  – “is recognized as a consumer-relevant category."

The French beauty giant plans to launch its Colorsonic at-home hair color device with oscillating nozzle in early 2023. L’Oreal showcased the product, along with a breakthrough hair color “reader” and custom mixing system for salon use, at the CES 2022 tech show in Las Vegas.

Beauty merger and acquisition activity accelerated in the US last year, with 75 deals by mid-October 2021, versus 48 in the prior-year period, according to investment banking firm Capstone Partners’ recent Beauty & Wellness report.

“There's been not enough investors' visibility to our consumer health business," recently promoted CEO Duato says at JP Morgan conference, With separate business, "investors are going to see the strength of our consumer health business, the number of iconic brands, the global scale and our penetration, the unique relationship that consumer have with our brands."

“We are positioned to move forward with either the Bausch + Lomb or Solta IPO quickly when market conditions are right for each of them,” CEO Joseph Papa says at J.P. Morgan conference, but the firm’s “next step” in the process of separating the two businesses was filing with the SEC an IPO registration for Bausch + Lomb.

Republican opposition to Califf over agency’s recent move to relax its Mifeprex restrictions is ominous since, in order be confirmed as commissioner, he’ll need enough GOP votes to make up for Democratic opposition over his opioid track record and connections to pharma industry.

A round-up of the latest health and wellness appointments: GSK makes addition to senior management teams in Europe; Reckitt appoints general counsel; and Norgine announces CEO change.

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

CFSAN decides on Center for Magnesium Education and Research LLC's 2016 petition requesting FDA authorize a qualified health claim about relationship between magnesium and reduced risk of high blood pressure, or hypertension.

Round-up of European consumer health news: Probiotics specialist BioGaia plots US expansion with acquisition of distribution partner; Spain's Rubió enters the dietary supplements space with Fisiopharma; and Portugal's Sidefarma receives investment from private-equity firm Atena.

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

France's self-medication market lags behind its European rivals. Why is that? A skeptical and over-cautious government and a stifling regulatory system may provide at least part of the answer, the Global Self-Care Federation's recently published Self-Care Readiness Index suggests.  

Regulatory barriers, government conservativism and a generous reimbursement system have all held back the development of France's self-care market. However, executive director of the French self-care industry association, Luc Besançon, thinks that the growing trends for prevention and e-commerce will change this in the future.